Return to homepagePandemic Pact

Discovery and Translational Sciences

Grant number: INV-042470

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2022
    2025
  • Known Financial Commitments (USD)

    $4,094,561
  • Funder

    Gates Foundation
  • Principal Investigator

    N/A

  • Research Location

    United Kingdom
  • Lead Research Institution

    SpyBiotech Ltd
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

SpyVector: an antigen decorated adenovirus vector for a broadly cross-protective coronavirus vaccine

2 Publications linked via Europe PMC

Last Updated:15 hours ago

View all publications at Europe PMC

Displayed and encoded antigens on adenovirus vectors optimize humoral and cellular immune responses in rhesus macaques.

Displayed and Encoded Antigens on Adenovirus Vectors Optimize Humoral and Cellular Immune Responses in Rhesus Macaques